Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.11 and last traded at C$0.12, with a volume of 10600 shares traded. The stock had previously closed at C$0.12.
Nanalysis Scientific Stock Performance
The business has a 50 day moving average of C$0.14 and a 200 day moving average of C$0.15. The company has a market capitalization of C$16.61 million, a P/E ratio of -2.40 and a beta of -0.52. The company has a quick ratio of 1.10, a current ratio of 1.42 and a debt-to-equity ratio of 71.72.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Featured Articles
- Five stocks we like better than Nanalysis Scientific
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
- How Does D-Wave’s New Simulator Change the Quantum Computing Landscape?
- Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
